Clinical trials
Not yet recruiting Phase 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 1 |
| Guangdong Ruishun Biotech Co., Ltd | 1 |
| M.D. Anderson Cancer Center | 1 |
| Michel Duval | 1 |
| Nationwide Children's Hospital | 1 |
| University Hospital, Basel, Switzerland | 1 |
| University of Arizona | 1 |
| Wake Forest University Health Sciences | 1 |
| Zhujiang Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma, B-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Recurrence | 3 |
| Leukemia | 2 |
| Leukemia, B-Cell | 2 |
| Cytokine Release Syndrome | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.